MVIS US Listed Biotech 25 Index
The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.
This page compares selected fundamental data of the MVIS Index to designated peer indices. The data is updated monthly.
|Trailing Price/Earnings (incl. negative)||44.15 |
|Trailing Price/Earnings (excl. negative)||23.45 |
|Price/Cash Flow||20.94 |
|Dividend Yield||0.51 |
|Net Debt to Equity||-1.46 |